Teresa Quattrin

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

T. Quattrin, S. Schwartz, N. Bohannon, 2004, Diabetes care.